Rucaparib 6.5μM R08 exp520

PARP1/2/3 inhibitor (Clovis), PARP1 mediates single-strand break repair, which can lead to replication-induced double strand breaks to form if not repaired; specifically target cancer with BRCA1, BRCA2 or PALB2 mutations; FDA granted an accelerated approval for use in cases of pretreated advanced ovarian cancer

  • Class / Subclass 1: DNA Damage, Repair and Replication / DNA Repair Inhibitor

Compound References

  • PubChem Name: Rucaparib phosphate
  • Synonyms: AG-014699 phosphate; PF-01367338 phosphate
  • CAS #: 459868-92-9
  • PubChem CID: 9931953
  • IUPAC: 6-fluoro-2-[4-(methylaminomethyl)phenyl]-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one;phosphoric acid
  • INCHI Name: InChI=1S/C19H18FN3O.H3O4P/c1-21-10-11-2-4-12(5-3-11)18-14-6-7-22-19(24)15-8-13(20)9-16(23-18)17(14)15;1-5(2,3)4/h2-5,8-9,21,23H,6-7,10H2,1H3,(H,22,24);(H3,1,2,3,4)
  • INCHI Key: FCCGJTKEKXUBFZ-UHFFFAOYSA-N
  • Molecular Weight: 421.4
  • Canonical SMILES: CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2.OP(=O)(O)O
  • Isomeric SMILES: N/A
  • Molecular Formula: C19H21FN3O5P

Compound Supplier

  • Supplier Name: Med Chem Express
  • Catalog #: HY-10617
  • Lot #: 29562

Compound Characterization

  • HRMS (ESI-TOF) m/z: (M+H)+ Calcd for C19H18FN3O 324.15067; found 324.15184

Dose Response Curve

  • Platform ID: Rucaparib
  • Min: 4.0175; Max: 99.5587





IC Concentration (µM)
IC10 3.6040
IC20 5.1380
IC30 6.5040
IC40 7.8900
IC50 9.4220
IC60 11.2500
IC70 13.6500
IC80 17.2800
IC90 24.6300


  • Round: 08
  • Dose: 6.5µM
  • Days of incubation: 8
  • Doublings: 3.6
  • Numbers of reads: 16082760
Sensitive/Resistant hits (FDR<0.05)CRANKSScore PlotTop 30 GenesScreen SimilarityTop 30 Sensitive GO termsTop 30 Resistant GO terms
36/13ScoresViewViewViewViewView

  • Last modified: 2026/01/15 21:36
  • by 127.0.0.1